RecruitingNCT07638553

Psilocybin-assisted therapy for alcohol use and depression

About this title

Medication studyAges 18+France

The study in practice

Understand this study

Listed age limits: from 18 years.

Listed locations: Bayonne and 7 more locationsSee all locations and recruitment
Study phase: Phase 3

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Study start dateStarted: June 30, 2026

Recruitment status: Recruiting
Enrollment listed in the registry: 172
Sponsor: Centre Hospitalier Universitaire de Nīmes
Sponsor type: Unknown or unclear
Study type: Drug
Intervention type: Medication / drug
Study phase: Phase 3
Locations: France
Age range: Over 18 Years
Official registry ID: NCT07638553
Official title: Show the full official title
Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms

Recruiting

Bayonne · Besançon · Bordeaux

5 more locations

A listed location does not confirm current availability.

FAQ

Who is behind this study?

The study sponsor is Centre Hospitalier Universitaire de Nīmes.

Does this study involve medication?

Yes. The study involves medication, including Psilocybin (high dose) and Psilocybin (low dose).

Who can participate?

Listed age limits: from 18 years.

Is this study still recruiting?

The registry lists this study as recruiting.